ELZA at ESCRS 2024 – Day 2
Saturday, September 7 is the second day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Mark Hillen
September 7, 2024
Saturday, September 7 is the second day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Friday, September 6 was the first day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons. Here’s a collection of images from that day.
ELZA-PACE not only improves corneal biomechanics (just like regular CXL) but by flattening the cone significantly, also enhances patients’ visual quality. The results so far indicate that patients treated with this method have better visual outcomes compared to traditional CXL treatments.
Here’s an overview of what ELZA’s surgeons and researchers are presenting in Barcelona this year. ELZA at ESCRS 2024.
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection.
Ophthalmologie Nachrichten recently featured an article from the ELZA Institute, highlighting advancements in corneal cross-linking (CXL). This new approach allows the procedure to be conducted at the slit lamp, significantly reducing costs and extending access to advanced eye care in underserved regions. The innovative method is especially effective for treating keratoconus and infectious keratitis. By optimizing UV exposure times, ELZA’s researchers have made CXL more efficient and accessible, democratizing high-quality ophthalmic treatments globally.
CXL at the slit lamp uses the same UV irradiation settings and riboflavin concentration as in the operating room, achieving identical results. Patients generally tolerate the procedure well, especially with adjustments for comfort and higher UV intensities that shorten treatment time.
ELZA’s medical director, Prof. Dr. Farhad Hafezi MD, PhD, FARVO, was invited to give two lectures this afternoon at the 18th Annual Meeting of the Moroccan Society of Refractive Surgery and Implantology (SAMIR) in Rabat, Morocco.
ELZA’s research has led to the development of portable corneal cross-linking devices which democratize access to essential eye care, transforming treatment for keratoconus and infectious keratitis in low-to-middle-income countries.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.
